Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

227 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comment on: Developing standards of care for patients with juvenile idiopathic arthritis.
Beresford MW, Cleary AG, Foster HE, Hutchinson E, Baildam EM, Davies K; UK MCRN/Arthritis Research UK Paediatric Rheumatology Clinical Studies Group; British Society of Paediatric and Adolescent Rheumatology. Beresford MW, et al. Among authors: foster he. Rheumatology (Oxford). 2010 Nov;49(11):2227-9. doi: 10.1093/rheumatology/keq215. Epub 2010 Jul 22. Rheumatology (Oxford). 2010. PMID: 20650973 No abstract available.
Trends in paediatric rheumatology referral times and disease activity indices over a ten-year period among children and young people with Juvenile Idiopathic Arthritis: results from the childhood arthritis prospective Study.
McErlane F, Foster HE, Carrasco R, Baildam EM, Chieng SE, Davidson JE, Ioannou Y, Wedderburn LR, Thomson W, Hyrich KL. McErlane F, et al. Among authors: foster he. Rheumatology (Oxford). 2016 Jul;55(7):1225-34. doi: 10.1093/rheumatology/kew021. Epub 2016 Mar 25. Rheumatology (Oxford). 2016. PMID: 27016664 Free PMC article.
Use and effectiveness of rituximab in children and young people with juvenile idiopathic arthritis in a cohort study in the United Kingdom.
Kearsley-Fleet L, Sampath S, McCann LJ, Baildam E, Beresford MW, Davies R, De Cock D, Foster HE, Southwood TR, Thomson W, Hyrich KL. Kearsley-Fleet L, et al. Among authors: foster he. Rheumatology (Oxford). 2019 Feb 1;58(2):331-335. doi: 10.1093/rheumatology/key306. Rheumatology (Oxford). 2019. PMID: 30358861 Free PMC article.
Methotrexate persistence and adverse drug reactions in patients with juvenile idiopathic arthritis.
Kearsley-Fleet L, Vicente González L, Steinke D, Davies R, De Cock D, Baildam E, Beresford MW, Foster HE, Southwood TR, Thomson W, Hyrich KL; Biologics for Children with Rheumatic Diseases (BCRD) Study and the British Society for Paediatric and Adolescent Rheumatology Etanercept Cohort Study (BSPAR-ETN). Kearsley-Fleet L, et al. Among authors: foster he. Rheumatology (Oxford). 2019 Mar 8;58(8):1453-8. doi: 10.1093/rheumatology/kez048. Online ahead of print. Rheumatology (Oxford). 2019. PMID: 30851113 Free PMC article.
The risk of uveitis in patients with JIA receiving etanercept: the challenges of analysing real-world data.
Davies R, De Cock D, Kearsley-Fleet L, Southwood T, Baildam E, Beresford MW, Foster HE, Thomson W, Ramanan AV, Hyrich KL; British Society for Paediatric and Adolescent Rheumatology Etanercept Cohort Study (BSPAR-ETN) and the Biologics for Children with Rheumatic Diseases (BCRD) study. Davies R, et al. Among authors: foster he. Rheumatology (Oxford). 2020 Jun 1;59(6):1391-1397. doi: 10.1093/rheumatology/kez449. Rheumatology (Oxford). 2020. PMID: 31605484 Free PMC article.
227 results